ICE: Intracardiac Ultrasound Within the Left Atrium During Radiofrequency Ablation of Nonvalvular Atrial Fibrillation
- Conditions
- Atrial Fibrillation
- Registration Number
- NCT02028143
- Lead Sponsor
- Gregory Jones
- Brief Summary
Imaging Real Time within the Left atrial chamber Enhances safety and efficacy of Radiofrequency Ablation of Atrial Fibrillation
- Detailed Description
Atrial fibrillation is the most common rhythm disturbance affecting the human population.
1. Its prevalence increases with age and can be found in \>8% of humans over the age of eighty;
2. Radiofrequency ablation for drug refractory nonvalvular atrial fibrillation has become a common therapy available to patients. It has been shown to be both efficacious and cost effective;
3. The standard approach to atrial fibrillation involves electrical isolation of the pulmonary veins (PVI) from the rest of the atrium chamber. This involves moving a 3.5mm tip ablation catheter point to point around the PV structures until an encircling ablation line is formed. This can be made difficult by not knowing if the tip is in good contact with the atrial tissue. In addition the esophagus is a posterior lying structure and injury to the esophagus by ablating the overlying tissue has been reported, at times fatal;
4. Currently, intracardiac imaging of the left atrium has FDA approval in the right atrial chamber. This leads to difficulty in visualizing tip tissue interface, and important left sided structures such as carina, ligaments, and esophagus. By placing the tip of the ICE catheter in the left atrium, enhanced visualization of the tip tissue interface may lead to more effective ablation points, fewer needed ablation points, and enhanced safety by avoiding placement over adjacent noncardiac structures.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
- Age 18 to 80 years
- Recommended for radiofrequency ablation of nonvalvular atrial fibrillation
- none
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method number of lesions requiring ablation to obtain Electrical Isolation PV System during procedure to assess the number of lesions requiring ablation to obtain Electrical Isolation PV system
- Secondary Outcome Measures
Name Time Method to assess number of lesions to obtain Electrical Isolation PV system during procedure Evaluate the time required to obtain electrical isolation of PV system
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Wellmont CVA Heart Institute
🇺🇸Kingsport, Tennessee, United States
Wellmont CVA Heart Institute🇺🇸Kingsport, Tennessee, United States